288 related articles for article (PubMed ID: 20560948)
1. The cost-effectiveness of targeted or universal screening for vasa praevia at 18-20 weeks of gestation in Ontario.
Cipriano LE; Barth WH; Zaric GS
BJOG; 2010 Aug; 117(9):1108-18. PubMed ID: 20560948
[TBL] [Abstract][Full Text] [Related]
2. Vasa previa screening strategies: decision and cost-effectiveness analysis.
Sinkey RG; Odibo AO
Ultrasound Obstet Gynecol; 2018 Oct; 52(4):522-529. PubMed ID: 29786153
[TBL] [Abstract][Full Text] [Related]
3. Prevention of stillbirth: impact of two-stage screening for vasa previa.
Zhang W; Geris S; Beta J; Ramadan G; Nicolaides KH; Akolekar R
Ultrasound Obstet Gynecol; 2020 May; 55(5):605-612. PubMed ID: 31840871
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of transvaginal ultrasound cervical length screening in singletons without a prior preterm birth: an update.
Werner EF; Hamel MS; Orzechowski K; Berghella V; Thung SF
Am J Obstet Gynecol; 2015 Oct; 213(4):554.e1-6. PubMed ID: 26071914
[TBL] [Abstract][Full Text] [Related]
5. Velamentous insertion of umbilical cord with vasa praevia: case series and literature review.
Bohîlțea RE; Cîrstoiu MM; Ciuvica AI; Munteanu O; Bodean O; Voicu D; Ionescu CA
J Med Life; 2016; 9(2):126-9. PubMed ID: 27453740
[TBL] [Abstract][Full Text] [Related]
6. Incidence of and risk indicators for vasa praevia: a systematic review.
Ruiter L; Kok N; Limpens J; Derks JB; de Graaf IM; Mol B; Pajkrt E
BJOG; 2016 Jul; 123(8):1278-87. PubMed ID: 26694639
[TBL] [Abstract][Full Text] [Related]
7. Prenatal diagnosis and management of vasa previa in twin pregnancies: a case series and systematic review.
Jauniaux E; Melcer Y; Maymon R
Am J Obstet Gynecol; 2017 Jun; 216(6):568-575. PubMed ID: 28153653
[TBL] [Abstract][Full Text] [Related]
8. The impact of ultrasound-based antenatal screening strategies to detect vasa praevia in the United Kingdom: An exploratory study using decision analytic modelling methods.
Ruban-Fell B; Attilakos G; Haskins-Coulter T; Hyde C; Kusel J; Mackie A; Rivero-Arias O; Thilaganathan B; Thomson N; Visintin C; Marshall J
PLoS One; 2022; 17(12):e0279229. PubMed ID: 36538562
[TBL] [Abstract][Full Text] [Related]
9. Natural history of vasa previa across gestation using a screening protocol.
Rebarber A; Dolin C; Fox NS; Klauser CK; Saltzman DH; Roman AS
J Ultrasound Med; 2014 Jan; 33(1):141-7. PubMed ID: 24371109
[TBL] [Abstract][Full Text] [Related]
10. Velamentous cord insertion: results from a rapid review of incidence, risk factors, adverse outcomes and screening.
Buchanan-Hughes A; Bobrowska A; Visintin C; Attilakos G; Marshall J
Syst Rev; 2020 Jun; 9(1):147. PubMed ID: 32576295
[TBL] [Abstract][Full Text] [Related]
11. [Vasa praevia rupture in velamentous insertion of the umbilical cord: the importance of prenatal diagnosis].
Pérez Rodríguez MJ; de Frutos Moneo E; Nieto Llanos S; Clemente Pollán J
An Pediatr (Barc); 2014 Dec; 81(6):393-5. PubMed ID: 24316300
[TBL] [Abstract][Full Text] [Related]
12. Perinatal Outcomes Associated With Isolated Velamentous Cord Insertion in Singleton and Twin Pregnancies.
Sinkin JA; Craig WY; Jones M; Pinette MG; Wax JR
J Ultrasound Med; 2018 Feb; 37(2):471-478. PubMed ID: 28850682
[TBL] [Abstract][Full Text] [Related]
13. Ante- and intrapartum diagnosis of vasa praevia in singleton pregnancies by colour coded Doppler sonography.
Baschat AA; Gembruch U
Eur J Obstet Gynecol Reprod Biol; 1998 Jul; 79(1):19-25. PubMed ID: 9643398
[TBL] [Abstract][Full Text] [Related]
14. The cost-effectiveness of expanding newborn screening for up to 21 inherited metabolic disorders using tandem mass spectrometry: results from a decision-analytic model.
Cipriano LE; Rupar CA; Zaric GS
Value Health; 2007; 10(2):83-97. PubMed ID: 17391418
[TBL] [Abstract][Full Text] [Related]
15. [Vasa previa: Of the diagnosis to neonatal prognosis].
Aissi G; Sananes N; Veujoz M; Felder A; Kasbaoui SM; Trieu NT; Favre R; Nisand I
J Gynecol Obstet Biol Reprod (Paris); 2013 Oct; 42(6):591-5. PubMed ID: 23287072
[TBL] [Abstract][Full Text] [Related]
16. Systematic screening for vasa previa at the 20-week anomaly scan.
Gross A; Markota Ajd B; Specht C; Scheier M
Acta Obstet Gynecol Scand; 2021 Sep; 100(9):1694-1699. PubMed ID: 34077551
[TBL] [Abstract][Full Text] [Related]
17. Perinatal Mortality Despite Prenatal Diagnosis of Vasa Previa: A Systematic Review.
Heyborne K
Obstet Gynecol; 2023 Sep; 142(3):519-528. PubMed ID: 37535966
[TBL] [Abstract][Full Text] [Related]
18. Universal cervical-length screening to prevent preterm birth: a cost-effectiveness analysis.
Werner EF; Han CS; Pettker CM; Buhimschi CS; Copel JA; Funai EF; Thung SF
Ultrasound Obstet Gynecol; 2011 Jul; 38(1):32-7. PubMed ID: 21157771
[TBL] [Abstract][Full Text] [Related]
19. Is scanning for vasa previa important for singleton pregnancies that started as multiple conceptions?
Melcer Y; Pekar-Zlotin M; Wolf B; Betser M; Dvash S; Zilberman Sharon N; Maymon R
Eur J Obstet Gynecol Reprod Biol; 2019 Jul; 238():100-103. PubMed ID: 31128531
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of prenatal screening methods for congenital heart defects in pregnancies conceived by in-vitro fertilization.
Chung EH; Lim SL; Havrilesky LJ; Steiner AZ; Dotters-Katz SK
Ultrasound Obstet Gynecol; 2021 Jun; 57(6):979-986. PubMed ID: 32304621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
